- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Morepen Laboratories Ltd (MORL)
Morepen Laboratories Ltd stock price live, this page displays NSE MORL stock exchange data. View the MORL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Morepen Laboratories Ltd real time stock price chart below.
What Is the Morepen Laboratories Ltd Stock Price Today?
The Morepen Laboratories Ltd stock price today is 111.97.
What Is the Stock Symbol for Morepen Laboratories Ltd?
The stock symbol for Morepen Laboratories Ltd is "MORL."
What Stock Exchange Does Morepen Laboratories Ltd Trade On?
Morepen Laboratories Ltd is listed and trades on the NSE stock exchange.
Is Morepen Laboratories Ltd a Good Stock to Buy?
Determining whether Morepen Laboratories Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MORL quote. (ISIN: INE083A01026)
What Is the Morepen Laboratories Ltd Stock Price Today?
The Morepen Laboratories Ltd stock price today is 111.97.
What Is the Stock Symbol for Morepen Laboratories Ltd?
The stock symbol for Morepen Laboratories Ltd is "MORL."
What Stock Exchange Does Morepen Laboratories Ltd Trade On?
Morepen Laboratories Ltd is listed and trades on the NSE stock exchange.
Is Morepen Laboratories Ltd a Good Stock to Buy?
Determining whether Morepen Laboratories Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MORL quote. (ISIN: INE083A01026)
111.97
+8.32(+8.03%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
103.55
114.00
52 wk Range
33.05
114.00
Trading near 52-week High
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
103.55114.00
52 wk Range
33.05114.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.19%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.19%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
MORL Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Earnings
Latest Release
Aug 04, 2026
EPS / Forecast
1.03 / --
Revenue / Forecast
5.7B / --
Compare MORL to Peers and Sector
Metrics to compare | MORL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMORLPeersSector | |
|---|---|---|---|---|
P/E Ratio | 44.0x | 33.7x | −0.4x | |
PEG Ratio | 0.87 | 0.81 | 0.00 | |
Price/Book | 5.0x | 4.6x | 2.6x | |
Price / LTM Sales | 3.2x | 4.1x | 3.1x | |
Upside (Analyst Target) | - | 4.9% | 49.0% | |
Fair Value Upside | Unlock | −0.9% | 7.0% | Unlock |
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometers, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides OTC and healthcare products, including fever X for fever; Pain X for pain; Fiber-X for constipation; sat isabgol; Acidity X for acidity; Burnol, a first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand name. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Morepen Laboratories Ltd (MORL) Stock Price Today?
The Morepen Laboratories Ltd stock price today is 111.97 INR.
What Stock Exchange Does Morepen Laboratories Ltd Trade On?
Morepen Laboratories Ltd is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Morepen Laboratories Ltd?
The stock symbol for Morepen Laboratories Ltd is "MORL."
Does Morepen Laboratories Ltd Pay Dividends? What’s The Current Dividend Yield?
The Morepen Laboratories Ltd dividend yield is 0.19%.
What Is the Morepen Laboratories Ltd Market Cap?
As of today, Morepen Laboratories Ltd market cap is 61.86B INR.
What Is Morepen Laboratories Ltd's Earnings Per Share (TTM)?
The Morepen Laboratories Ltd EPS (TTM) is 2.55.
From a Technical Analysis Perspective, Is MORL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Morepen Laboratories Ltd Stock Split?
Morepen Laboratories Ltd has split 1 times.
How Many Employees Does Morepen Laboratories Ltd Have?
Morepen Laboratories Ltd has 1814 employees.
What is the current trading status of Morepen Laboratories Ltd (MORL)?
As of Sep 02, 2026, Morepen Laboratories Ltd (MORL) is trading at a price of 111.97 INR, with a previous close of 103.65 INR. The stock has fluctuated within a day range of 103.55 INR to 114.00 INR, while its 52-week range spans from 33.05 INR to 114.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.